Natera
Natera is seeking a Director of Bioinformatics and Machine Learning to lead technology and biomarker research for cancer early detection programs. This hands-on scientific leader will direct a team of scientists developing next-generation cell-free DNA assays across multi-cancer early detection, tissue-free molecular residual disease, and single-cancer screening. The role involves defining research roadmaps, overseeing computational study design, and translating research into clinical diagnostics.
Headquarters
Austin, Texas, United States
Company Size
1001-5000 employees
Founded
2004
Natera is a molecular diagnostics company that develops and commercializes cell-free DNA testing for oncology, women's health, organ health, and rare disease. Its tests are used for cancer detection and monitoring, noninvasive prenatal and carrier screening, transplant rejection assessment, and genomic analysis for rare diseases. Natera's clinically validated tests are processed in CAP/CLIA-certified labs and supported by over 400 peer-reviewed publications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Natera.
Natera's 1.18% Stock Decline Despite $280M Volume Surge Ranks 429th in Trading Activity
14 hours ago
Research Fellow (Bioinformatics)
Nanyang Technological University
Senior Bioinformatics Research Engineer
Freenome
Senior Computational Biologist
Memorial Sloan Kettering Cancer Center
Associate Principal Bioinformatics Scientist
Abbott Laboratories
Bioinformatics Scientist, Machine Learning
SAGA Diagnostics
Staff Bioinformatics Scientist
Exact Sciences Corporation